Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Ann Thorac Surg. 2022 Dec 12;117(1):206–212. doi: 10.1016/j.athoracsur.2022.12.013

TABLE 4.

Intraoperative and Postoperative Outcomes of Lung Transplant Recipients by Postreperfusion sPAP

Variable Postreperfusion sPAP <37 mm Hg
(n = 39)
Postreperfusion sPAP ≥37 mm Hg
(n = 32)
P Value
Pulmonary artery pressure
 Prereperfusion sPAP 49.2 ± 21.2 46.9 ± 20.3 .65
Intraoperative outcomes
 Operative time, h 7.8 ± 1.2 7.9 ± 1.1 .55
 Intraoperative blood transfusion: pRBC 2.0 ± 2.1 1.7 ± 1.7 .54
 Intraoperative blood transfusion: FFP 0.5 ± 1.2 0.6 ± 1.2 .79
 Intraoperative blood transfusion: platelets 0.3 ± 0.7 0.1 ± 0.3 .17
 Ischemic time, h 5.7 ± 2.0 5.6 ± 0.8 .93
 Venoarterial ECMO use 34 (87.2) 29 (90.6) .94
 Venoarterial ECMO time, h 3.3 ± 1.7 3.2 ± 0.6 .72
Postoperative outcomes
 PGD grade 2/3 7 (17.9) 23 (71.9) <.001
 Acute kidney injury 15 (38.5) 11 (34.4) .91
 Dialysis 1 (2.6) 4 (12.5) .25
 Stroke 1 (2.6) 2 (6.3) .86
 Bowel ischemia 0 (0) 1 (3.1) .92
 Digital ischemia 0 (0) 2 (6.3) .39
 Intensive care unit stay, d 14.6 ± 9.9 21.8 ± 22.2 .07
 Posttransplant ventilator, d 6.1 ± 7.8 9.8 ± 18.8 .26
 Hospital stay, d 22.3 ± 13.0 25.6 ± 21.1 .42

Values are presented as mean ± SD or n (%). ECMO, extracorporeal membrane oxygenation; FFP, fresh frozen plasma; PGD, primary graft dysfunction; pRBC, packed red blood cells; sPAP, systolic pulmonary artery pressure.